BRAF-V600Eexpression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting

(2013) Miriam Merad et al.   Annual Review of Immunology

Rapid Detection and Quantitation ofBRAFMutations in Hairy Cell Leukemia Using a Sensitive Pyrosequencing Assay

(2012) Shalini Verma et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia

(2012) S. Schnittger et al.   BLOOD

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

(2012) J. Haroche et al.   BLOOD

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

(2012) J. Haroche et al.   BLOOD

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

(2012) F. Sahm et al.   BLOOD

Identification of the V600D mutation in Exon 15 of theBRAFoncogene in congenital, benign langerhans cell histiocytosis

(2012) Rina Kansal et al.   GENES CHROMOSOMES & CANCER

B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease

(2012) Takeshi Satoh et al.   PLoS One

Conditional Deletion of TGF-βR1 Using Langerin-Cre Mice Results in Langerhans Cell Deficiency and Reduced Contact Hypersensitivity

(2011) Sonja P. Zahner et al.   JOURNAL OF IMMUNOLOGY

Presence of Erdheim-Chester Disease and Langerhans Cell Histiocytosis in the Same Patient: A Report of 2 Cases

(2011) Stacy L Pineles et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recurrent BRAF mutations in Langerhans cell histiocytosis

(2010) G. Badalian-Very et al.   BLOOD

Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells

(2010) C. E. Allen et al.   JOURNAL OF IMMUNOLOGY

Lack of Retinoic Acid Leads to Increased Langerin-Expressing Dendritic Cells in Gut-Associated Lymphoid Tissues

(2009) Sun–Young Chang et al.   GASTROENTEROLOGY

Clofarabine in refractory Langerhans cell histiocytosis

(2008) Carlos Rodriguez-Galindo et al.   PEDIATRIC BLOOD & CANCER

Treatment of juvenile xanthogranuloma

(2008) Daniel G. Stover et al.   PEDIATRIC BLOOD & CANCER